Bausch + Lomb sees 6% Q4 sales gain ahead of planned IPO

The Bausch + Lomb unit of Bausch Health saw revenues in the fourth quarter of 2021 increase by 6 percent compared to the year earlier to $1,001 million. Revenues were 7 percent higher at constant currency rates, reflecting the continued positive impacts of recovery from the Covid-19 pandemic. Reported sales ...

To continue reading this article register now.

Already an Eyewear Intelligence subscriber? Sign in here.


Become a member today for full access from just €7,29 a week!

Buying a membership today will give you:

  • Unlimited access to - all insight and analysis available online
  • Our executive edition of Eyewear Intelligence (Digital Edition) - the must-read for all decision-makers in the industry
  • Weekly E-mail Briefing from the Chief Editor with the lastest analysis and most important industry developments
  • Case studies and best practices on business challenges
  • Guest chronicles, interviews, insights from industry experts and leaders that are shaping the future of the industry
  • Access to over 11,500 articles and analyses in the archive
  • Personal library to save articles and track your key content
  • Powerful search and intuitive navigation

Or sign-up for a trial month for just 9,90€. To continue reading this article register now.